Why Peptide Stability Matters: Impacts on Research Validity and Reproducibility
Peptide stability isn’t just a nice-to-have, it directly shapes the credibility of your entire experiment. When peptides degrade, their biological activity shifts or disappears altogether. That means your data becomes unreliable, skewed, or, worse, totally misleading. Imagine running a signaling pathway assay where the peptide meant to mimic growth hormone activity breaks down halfway through. Your results won’t just be off by a little, they’ll be compromised.
Studies routinely show that even a 10% to 20% loss of intact peptide can produce statistically significant changes in readouts, especially in receptor binding assays and enzyme inhibition work. I’ve seen this play out in a lab setting: a “weak” agonist turned into an apparent partial agonist simply because the stock had been sitting as a reconstituted solution for too long under suboptimal peptide storage conditions. No one caught it until LC-MS confirmed a new dominant peak. Big difference.
Degradation can alter binding affinity, solubility, or enzymatic interactions, which then throws off pharmacokinetics measurements and masks the true biological effect you’re trying to measure. Reproducibility takes the hit first. If one batch is slightly oxidized and another isn’t, your results won’t line up across repeats, across labs, or across time. You can’t replicate findings if the foundational materials aren’t consistent.
There’s also a serious economic hit. Research-grade peptides aren’t cheap. You’re looking at hundreds, sometimes thousands, of dollars per batch, especially if you source from reputable suppliers like Amino Pharm, who provide 99% purity with clinically tested, US-made peptides. Wasting that on degraded samples means reruns, delays, and more money sunk into storage, resynthesis, and extra QC.
And time is the part nobody budgets correctly.
If your peptides start breaking down, your entire study can slip by weeks or months. That’s time lost chasing artifacts instead of real biology. So when people ask what factors influence the stability and storage of research peptides? The honest answer is that stability isn’t a side topic, it’s the backbone of solid, repeatable science.
Chemical Factors That Influence Peptide Stability
Chemical factors largely determine how well peptides hold up over time. The amino acid sequence sets the stage, some residues are inherently fragile, others are more forgiving. Methionine and cysteine are frequent oxidation targets. Asparagine and glutamine tend to deamidate. Those changes can shift conformation, net charge, and even how readily the peptide adsorbs to plastic or glass during storage.
The main degradation pathways are hydrolysis, oxidation, deamidation, and racemization. Hydrolysis is peptide bond cleavage driven by water activity and pH, and it accelerates under acidic or basic conditions. Oxidation often hits sulfur-containing residues such as cysteine and methionine, commonly triggered by oxygen exposure, trace peroxides in solvents, or light. The result can be sulfoxide formation or disulfide scrambling, which is a real problem if you’re studying receptor interactions in growth hormone or muscle growth models.
Deamidation converts asparagine or glutamine into aspartic acid or glutamic acid (and sometimes isoaspartate forms), shifting charge and solubility. That can reduce receptor binding efficiency, change apparent potency, or distort pharmacokinetics. Racemization flips amino acids from the natural L-form to the D-form, which can blunt activity or change protease susceptibility. It tends to show up faster at higher temperatures or at pH extremes.
Post-translational style modifications can help or hurt, depending on the sequence and use case. Phosphorylation matters in signaling pathway research because it changes interaction sites and functional readouts. But the added group can introduce bonds that are more acid-labile, which increases hydrolysis risk under the wrong conditions. C-terminal amidation often improves stability by blocking reactive carboxyl chemistry, but it can reduce solubility, which complicates reconstitution and long-term handling (and yes, that can be annoying at the bench).
| Degradation Pathway | Targeted Residues/Groups | Effect on Peptide | Storage/Handling Impact |
|---|---|---|---|
| Hydrolysis | Peptide bonds (general) | Fragmentation, loss of activity | Sensitive to pH extremes and moisture |
| Oxidation | Methionine, Cysteine | Structural changes, altered folding | Avoid oxygen, light exposure |
| Deamidation | Asparagine, Glutamine | Charge alteration, solubility changes | Stable pH, low temperature recommended |
| Racemization | All amino acids (mostly L→D) | Loss of biological function | Minimize heat, extreme pH |
| What stands out in practice is how sequence composition drives real-world losses. Hydrophobic peptides tend to aggregate or stick to vial walls, so you “lose” material without any obvious degradation peak until you check recovery. Highly charged sequences can pull in water and speed up certain hydrolytic processes in solution. That’s where batch testing and analytical methods matter. You can’t just order peptides and hope for the best. Confirming identity, purity, and early degradation with HPLC and mass spectrometry is non-negotiable when your study depends on subtle shifts in muscle growth signaling or recovery markers. |
For anyone sourcing peptides, GMP certification is worth understanding, even for research use. It doesn’t guarantee a peptide will survive poor handling, but it does mean the manufacturing controls, documentation, and release testing are standardized. Amino Pharm’s peptides, for example, undergo rigorous batch testing to support consistent quality, which reduces the number of “mystery failures” that show up weeks into a project.
Chemical factors don’t just influence how long peptides last on the shelf. They decide whether the compound you’re dosing is the compound you think you’re dosing. Ignore them and you’ll end up chasing phantom effects, or worse, publishing them. That’s my mildly opinionated take, but it’s earned.
Peptide Stability – an overview (sciencedirect.com) covers these mechanisms in depth and is a solid resource if you want the full picture.
Physical and Environmental Conditions Affecting Peptide Integrity
Peptides are fragile little molecules. Their stability depends heavily on the environment they’re kept in.
Temperature is one of the biggest drivers. As temperature rises, degradation reactions speed up, often following Arrhenius behavior, so small increases can have outsized effects over weeks. That’s basic chemistry, but it matters a lot with research-grade material where purity and intact mass are the whole point. Elevated heat increases molecular motion, which raises the odds of bond cleavage, rearrangement, and aggregation. Store a peptide at room temperature long enough and you’ll often see hydrolysis or deamidation creep in, especially in solution. Cold storage isn’t a suggestion, it’s table stakes. Temperature effects on peptides are critical to consider for maintaining integrity.
Moisture adds another layer. Even lyophilized (freeze-dried) peptides can absorb water from humid air, and that water can kick off aggregation, hydrolysis, or oxidation. Leave a vial open during weighing, or store it somewhere with humidity swings, and you’re basically inviting trouble. In reconstituted samples, water is the reaction medium, so every variable in that solution matters: pH, dissolved oxygen, trace metals, and microbial contamination risk. Peptides are often hygroscopic, which makes these physicochemical changes more likely during storage and handling (biomedgrid.com). The humidity impact on peptides is often underestimated but significant.
Light exposure gets underestimated. UV and visible light can trigger photodegradation directly, or indirectly by generating reactive oxygen species that modify susceptible residues. Photolability depends on sequence, but aromatic residues and disulfide-containing peptides are common problem cases. This can shift apparent pharmacokinetics and distort experiments tied to signaling pathways or growth hormone mimetics. Amber vials, foil wraps, and opaque secondary containers help. Simple fix.
But freeze-thaw cycles are the quiet saboteur. Repeated freezing and thawing creates physical stress that can drive aggregation, partial unfolding, or precipitation. You might not notice until potency drops or variability spikes. Each cycle can be small, then it stacks up. Aliquoting into single-use volumes is boring lab work, but it prevents a lot of downstream chaos, and it keeps batch testing and analytical method results interpretable.
Physical conditions aren’t academic details. Temperature, moisture, light, and freeze-thaw stress all attack peptide integrity from different angles, and ignoring any one of them can undermine your work, no matter how clean the starting material was.
Optimal Storage Strategies for Different Peptide Forms
Storing peptides properly isn’t rocket science, but it does require discipline. The form your peptide arrives in, lyophilized powder or reconstituted solution, dictates what “good storage” actually means.
Lyophilized peptides are generally more stable because most degradation pathways need water. For long-term storage, -20°C to -80°C is typical, with ultra-low conditions preferred for the most sensitive sequences. Lower temperatures slow reaction kinetics and help preserve integrity for months, sometimes years, assuming the peptide was dry and clean to begin with. Packaging matters: airtight vials, inert gas backfill, or vacuum-sealed packaging reduces oxygen and moisture ingress. Desiccants like silica gel can help mop up residual humidity inside secondary packaging.
A regular fridge sounds fine until it isn’t. Temperature cycling from door openings, condensation, and inconsistent cold spots can introduce moisture and repeated micro-thaw events. That’s a bad trade for lyophilized storage. Ultra-low freezers are more stable. If you want practical guidance on preparing peptides before storage, I recommend checking out best practices for peptide water preparation, the small details there can make a big difference.
Reconstituted peptides are a different beast. Once dissolved, they’re exposed to hydrolysis, oxidation, adsorption to container surfaces, and microbial contamination. Many solutions don’t stay reliable beyond days to a few weeks at 2°C to 8°C, depending on sequence, concentration, buffer, and sterility. Solvent choice matters more than most people expect. Sterile water is common, dilute acetic acid is used for some sequences to keep pH in a safer window, and certain organic co-solvents can help solubility but may increase precipitation risk when you cool or freeze. You have to match the solvent system to the peptide’s chemistry. There’s no universal recipe. Peptide solubility is a key factor in choosing solvents and storage buffers.
Comparing lyophilized versus reconstituted forms, the shelf-life gap is stark. Lyophilized powders can remain usable for 1 to 2 years under ideal conditions. Reconstituted peptides often degrade within a month or less, sometimes much faster if the buffer is poorly chosen or the sample sees repeated handling. This isn’t just about “time on the label.” Bioactivity and signaling interactions can drift as the mixture changes, which is exactly how labs end up with inconsistent dose-response curves.
Handling and transport add another wrinkle. Shipping at ambient temperature is tempting and sometimes unavoidable, but it’s risky. Heat spikes in transit, humidity exposure, and light can all accelerate damage. Insulated packaging with cold packs and opaque materials reduces those hazards. When shipments arrive, move vials to proper storage right away. Don’t leave them on a countertop, and definitely not in a warm mailbox.
Here’s a quick comparison table for clarity:
| Peptide Form | Ideal Storage Temp | Packaging | Typical Stability | Handling Notes |
|---|---|---|---|---|
| Lyophilized Peptides | -20°C to -80°C | Airtight vial + desiccant + inert atmosphere | Up to 2 years (if dry & cold) | Avoid humidity, limit exposure to air |
| Reconstituted Peptides | 2°C to 8°C | Sterile vial, pH-appropriate solvent | Days to weeks | Use aliquots, minimize freeze-thaw cycles |
Amino Pharm supplies peptides at 99% purity, US-made, clinically tested for research use only, not for human consumption. Their quality control includes rigorous batch testing and analytical methods to
 |
If you want the most reliable data possible, treat storage as part of your method section, not an afterthought. It protects your budget and keeps experiments involving growth hormone, muscle growth, or recovery signaling pathways reproducible.
Degradation Pathways: How Peptides Break Down Over Time
Peptides don’t stay pristine forever. They break down, and the dominant failure mode depends on both chemistry and environment.
Hydrolysis is the classic culprit. Hydrolytic cleavage targets the peptide bonds linking amino acids, gradually chopping the molecule into smaller fragments. It speeds up in the presence of water, and it often accelerates when pH drifts acidic or basic. If your peptide sits in a poorly buffered solution with fluctuating pH, expect faster breakdown. Buffer systems matter because they stabilize the environment and slow hydrolysis by keeping pH in check. Effects of pH on peptides are therefore critical to monitor.
Oxidation is another major pathway that labs sometimes miss until it’s too late. Reactive oxygen species such as hydrogen peroxide and superoxide radicals attack susceptible residues, especially methionine, cysteine, and tryptophan. Oxidative damage can change conformation, reduce potency, or create new species that behave differently in assays. Methionine oxidation, for example, introduces sulfoxide groups that can alter receptor interactions in pathways tied to growth hormone release or muscle growth mechanisms. Oxidation of peptides is a key degradation concern.
Deamidation and isomerization are subtler, but they cause real headaches. Deamidation mainly affects asparagine and glutamine, converting them into aspartic acid or isoaspartic acid forms, which shifts charge distribution and can change folding and pharmacokinetics. Isomerization and related stereochemical changes can reduce receptor binding or alter enzymatic degradation rates. Both processes generally accelerate with elevated temperature and pH extremes, which is why sloppy storage shortens usable shelf life so quickly. Deamidation effects and racemization in peptides are important chemical pathways to consider.
Buffer composition can change degradation kinetics in ways that aren’t intuitive. Some buffers can catalyze hydrolysis or influence oxidation rates depending on ionic strength, trace metal content, and compatibility with the sequence. Phosphate buffers are often stable, but citrate or acetate systems can behave differently with certain peptides. That’s why stability studies and batch testing often include forced-degradation work across multiple buffer conditions, it’s the fastest way to identify a safer storage medium for a given sequence.
Humidity and temperature fluctuations compound everything. Peptides are often hygroscopic, so they pull moisture from air, which can accelerate hydrolysis and oxidation even in “dry” vials if you handle them carelessly. Freeze-thaw cycles add physical stress that increases aggregation and fragmentation risk. Analytical methods like HPLC and mass spectrometry are how you keep this honest over time, especially when you’re trying to answer what factors influence the stability and storage of research peptides? with data instead of guesswork.
If you’re curious about how this plays out under real conditions, a recent study on peptide assay challenges reports that storage at 4°C with desiccants and inert atmospheres can extend peptide half-life by up to 50% compared to room temperature without humidity control (Identifying Trending Issues in Assay of Peptide … (biomedgrid.com)). Caveat: the exact gain depends heavily on sequence and packaging, so treat that number as directional, not universal.
Sequence-Specific and Structural Factors Influencing Stability
Not all peptides behave the same once they leave the synthesizer. Sequence-specific stability depends on amino acid composition, length, and what the chain “wants” to do in solution. Short peptides often fall apart faster because they have fewer intramolecular contacts to hold a preferred conformation. Longer sequences can form secondary structure, sometimes even compact folds, that reduce solvent access to vulnerable bonds and slow chemical degradation.
Alpha-helices and beta-sheets aren’t just textbook diagrams, they can physically limit water and oxygen exposure at the backbone. Tertiary folding can also bury oxidation-prone side chains (Met, Trp, Cys) away from the bulk solution, which changes the degradation kinetics in a measurable way. Insulin is a clean example: it’s a peptide hormone with a defined fold and disulfide architecture, and it generally tolerates handling better than a similar-length random-coil research peptide. That structural “shielding” shows up as longer shelf life and, downstream, more consistent receptor binding and assay readouts. Big difference.
Post-translational modifications add another variable, and they don’t always help. Phosphorylation, glycosylation, and methylation can stabilize a preferred conformation or reduce protease susceptibility, but certain motifs become more oxidation- or deamidation-prone after modification, especially around Asn/Gln and Met. In research settings, people often introduce non-canonical residues, D-amino acids, N-methylated residues, or end-caps like acetylation/amidation, to slow enzymatic cleavage and extend in vitro half-life. That strategy can be effective, but it’s not magic, you still need real stability data for your buffer, pH, and temperature (and yes, the solvent system matters more than many teams admit).
Here’s a practical comparison: native growth hormone-releasing peptides versus analogs such as ipamorelin and sermorelin often show noticeably different stability profiles and functional persistence in cell-based assays. If you want a side-by-side breakdown, the comparison on ipamorelin vs sermorelin does a good job showing how small sequence edits can change durability and biological behavior.
So, what factors influence the stability and storage of research peptides? Sequence, structure, and modifications set the baseline, then your storage conditions either respect that baseline or wreck it.
Best Practices for Preserving Research-Grade Peptide Integrity
Peptides are touchy. Temperature swings, moisture, trace metals, and a little sloppy technique can turn “99% purity” into noisy data surprisingly fast. Treat them like high-value reagents, because that’s what they are.
Start with temperature control. Most labs default to -20°C, but plenty of sequences are better kept at -80°C, especially if they’re oxidation-prone, contain disulfides, or will sit for months between uses. Some peptides degrade faster than people expect at 4°C, and room temperature exposure during “quick bench work” adds up over a week. And freeze-thaw cycles? They’re a quiet killer. Aliquot on day one into single-use or single-week vials, then stop thawing the same tube over and over.
Labeling sounds basic, but it’s where many workflows fail. Use solvent-resistant labels and include batch number, concentration (if reconstituted), solvent/buffer, date opened, and a realistic discard date based on stability data. If your lab runs multiple similar peptides, add an internal ID that ties back to the certificate of analysis and your storage log. It’s boring until it saves an entire study.
You also can’t “eyeball” stability. Periodic checks with HPLC and/or LC-MS are the fastest way to catch hydrolysis, oxidation, deamidation, or truncation before your assays drift. In one peptide QC run I reviewed last year, a signaling peptide looked fine visually, but LC-MS showed a clear +16 Da oxidation peak after a month at -20°C in a frequently opened freezer box. The biology team had already flagged a creeping EC50 shift. The analytics explained it.
Stabilizers can help, sometimes. Cryo/lyo protectants like trehalose or mannitol are commonly used to reduce peptide aggregation and improve reconstitution consistency, and inert gas backfilling (nitrogen or argon) during lyophilization and storage can reduce oxidative stress. Just be careful with additives in solution, they can interfere with downstream assays, bind to plastic, or change pH over time. Worth noting.
Documentation is what turns “best practices” into repeatable science. Keep a log of storage temperature, freeze-thaw events, reconstitution solvent, pH, and any analytical results. When a batch starts losing potency early, you’ll see patterns, like a specific freezer location with temperature cycling, or a recurring issue tied to a particular buffer system. Our clinic sources peptides from Amino Pharm, which provides clinically tested, 99% purity, US-made peptides, but even strong upstream QC won’t rescue poor handling. These are research-grade materials, not for human use, so your lab’s SOPs are the final line of defense.
Real-World Examples: Common Pitfalls and How to Avoid Them
Peptides can look stable right up until they aren’t.
Freeze-thaw abuse is the classic failure mode. I once worked with a lab that thawed and refroze the same vial for “just a few microliters” across several days. By week two, their muscle growth assays were all over the place. HPLC showed new minor peaks, and MS confirmed fragmentation consistent with repeated stress and partial aggregation. The fix was simple: aliquot into single-use vials immediately on receipt, then keep working stocks separate from long-term stocks. Obvious, sure, but it’s still one of the most common mistakes I see.
Shipping is the other recurring problem. If peptides ship without dry ice, with inadequate insulation, or get stuck in transit for 48+ hours, you should assume some degradation risk, especially in warm climates. A colleague saw roughly a 40% potency loss in a growth hormone-related peptide panel after a summer delay, confirmed by assay performance and follow-up analytics. Cold chain logistics aren’t optional if you care about reproducibility, and if you’re unsure, ask for shipping stability information and acceptance criteria. Amino Pharm, for example, includes this info with their batches, which makes planning easier and reduces guesswork.
Moisture exposure is sneakier, and it ruins peptides quietly. One lab lost months of signaling pathway work because vials weren’t sealed well after repeated access, and the lyophilized material picked up humidity. Hygroscopic peptides pull in water, hydrolysis accelerates, aggregation becomes more likely, and reconstitution gets inconsistent. The practical fixes are cheap: desiccants in sealed storage boxes, vacuum sealing for long-term storage, and routine inspection of caps, O-rings, and vial threads (people forget those).
Troubleshooting storage problems comes down to vigilance and verification. Watch temperature logs, minimize freeze-thaw, control humidity, and confirm integrity with batch testing when the data start to drift. And if you want a deeper grasp on peptide mechanisms, check out this resource on semaglutide peptides understanding mechanism of semaglutide research peptide.
Peptide storage pitfalls are brutal. But they’re preventable.
Frequently Asked Questions About Peptide Stability and Storage
Got questions about peptide stability? You’re not the only one. Handling research-grade peptides correctly can make or break your experiments, so let’s clear up some of the most common concerns.
How long can I store peptides before they degrade? It depends on the peptide and the form you’re storing. Lyophilized peptides generally last far longer than reconstituted solutions. When stored dry at -20°C or colder, many peptides remain usable for months, and sometimes years, if moisture and oxygen exposure are controlled. Once you reconstitute, the clock speeds up fast, days to weeks is common, and that window depends heavily on pH, buffer composition, and temperature. Aliquoting small volumes before freezing is standard for a reason.
What storage conditions do peptides hate most? Heat and moisture, with oxygen close behind. Many peptides are hygroscopic, so brief exposure to ambient air during weighing or vial access can introduce enough water to increase hydrolysis and promote oxidation. Repeated freeze-thaw cycles also cause trouble, each thaw can shift conformation, encourage aggregation, or increase adsorption to tube walls. And temperature fluctuations matter, not just the absolute temperature. A 2024 review on peptide encapsulation reported that even modest temperature instability can accelerate breakdown by altering conformation and microenvironment effects (source).
How can I tell if my peptides have degraded? Sometimes you’ll see it, discoloration, clumping, or poor solubility. Often you won’t. HPLC and mass spectrometry are the workhorses for detecting new impurity peaks, oxidation products, deamidation, and truncations. If you’re running functional assays, drifting potency or inconsistent dose-response curves can be an early warning, but biology alone won’t tell you the chemical “why.” Analytical confirmation saves time.
And if you want to get more systematic, learning to spot issues by reading a peptide certificate of analysis a researchers checklist can prevent a lot of avoidable mistakes. Remember, these peptides are for research only, not human use, so maintaining integrity and traceability sits with your lab.
Frequently Asked Questions
How long can research peptides be stored without significant degradation?
Storage time depends on the peptide’s sequence, formulation, and container integrity, plus temperature and humidity control. Lyophilized (freeze-dried) peptides stored at -20°C or below often remain stable for months to years when protected from moisture and oxygen. Reconstituted peptides are far less stable and commonly degrade within days to a few weeks, even at 2 to 8°C. If your experiments are sensitive, treat “manufacturer guidance” as a starting point and confirm with periodic HPLC or LC-MS.
What are the most common causes of peptide degradation during storage?
Most degradation comes from hydrolysis, oxidation, deamidation, and aggregation, driven by heat, moisture, oxygen, light exposure, and pH drift. Trace contaminants can matter too, including proteases, residual acids from synthesis, or metal ions that catalyze oxidation. If you’re asking what factors influence the stability and storage of research peptides, these chemical pathways are the practical answer, because they’re what your storage protocol is trying to slow down.
Is it better to store peptides lyophilized or reconstituted?
Lyophilized storage is usually the better choice for long-term stability because it reduces hydrolysis risk and often slows oxidation and aggregation. Reconstitute only what you’ll use in a short window, then freeze aliquots if the peptide tolerates it. One caveat: some peptides reconstitute poorly after long storage unless you control humidity and use an appropriate solvent system, so plan reconstitution conditions ahead of time.
How can freeze-thaw cycles affect peptide stability?
Freeze-thaw cycles can promote aggregation, precipitation, and conformational changes, and they can increase adsorption losses to plastic surfaces. Each cycle adds stress, especially for peptides with hydrophobic segments or those prone to self-association. Minimizing cycles by aliquoting into single-use vials is one of the highest-impact steps you can take.
Are there additives that can improve peptide stability during storage?
Sometimes. Antioxidants and oxygen control (nitrogen/argon headspace) can reduce oxidation, and lyoprotectants like trehalose or mannitol can improve stability during freeze-drying and reconstitution. Buffer selection matters too, because pH and ionic strength influence deamidation, hydrolysis, and aggregation rates. The honest answer is that additives should be validated for your specific peptide and assay, because what stabilizes one sequence can interfere with another (or with your readout).
References
- “Peptide Stability – an overview” , sciencedirect.com , https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/peptide-stability
- “High-capacity information storage using peptide …” , nature.com , https://www.nature.com/articles/s43246-025-00915-y
- “Identifying Trending Issues in Assay of Peptide …” , biomedgrid.com , https://biomedgrid.com/pdf/AJBSR.MS.ID.002974.pdf
- “Exploring the impact of encapsulation on the stability and …” , frontiersin.org , https://www.frontiersin.org/journals/chemistry/articles/10.3389/fchem.2024.1423500/full
- “Drug stability: How storage conditions affect their performance” , vitalrecord.tamu.edu , https://vitalrecord.tamu.edu/drug-stability-storage-conditions-affect-performance/
- “Common Variables That Affect Peptide Stability in a Research …” , davidlindberg.co , https://davidlindberg.co/common-variables-that-affect-peptide-stability-in-a-research-setting/
- “How Peptide Stability Affects Research Results” , ghostlabzresearch.com , https://ghostlabzresearch.com/how-peptide-stability-affects-research-results/
- “Peptide Stability: Factors That Affect Research Outcomes” , pepamino.com , https://pepamino.com/blog/peptide-handling
- “WORKING WITH PEPTIDES” , proimmune.com , https://www.proimmune.com/wp-content/uploads/2021/08/ST55.pdf
- “ICH Q1 Guideline on stability testing of drug substances and …” , ema.europa.eu , https://www.ema.europa.eu/en/documents/scientific-guideline/draft-ich-q1-guideline-stability-testing-drug-substances-drug-products-step-2b_en.pdf
